In short. Early injectables, early devices and maintenance programmes, none of which has been shown to prevent anything from happening.
Key points
- Every claim in this category is biologically plausible, and plausibility is what makes them persuasive.
- It is not what makes them true, and the history of this field is largely a history of mechanisms that did not survive being tested.
Three claims carry most of the prejuvenation market, and the evidence does not carry any of them. Each fails for a slightly different reason, and the reasons are worth taking separately.
Early injectables
The claim is that treating volume early prevents the loss that would otherwise occur later. Filler adds volume to soft tissue where it is placed, and it does not stop the processes that reduce volume elsewhere or that change the skin itself. A face that is maintained is a face that is being treated, not one that has stopped changing. The comparison that would be needed — treated against untreated, over years, with a graded appearance — has not been made, and where the person has no finding there is no baseline from which to make it.
Early devices
The claim is that stimulating collagen while the skin is healthy builds a reserve against laxity later. The reasoning is plausible and it is reasoning. Demonstrating it would require following treated and untreated people long enough for laxity to develop and to be measured consistently, which nobody has done for any device in this category. What exists instead is short-term evidence about collagen and texture, which is a different claim and does not extend to prevention.
A mechanism is a reason to study something
Every claim in this category is biologically plausible, and plausibility is what makes them persuasive. It is not what makes them true, and the history of this field is largely a history of mechanisms that did not survive being tested.
Maintenance programmes
A maintenance programme is repeated treatment, and repeating it keeps its effects present rather than preventing anything. That distinction is worth holding on to, because the word maintenance sounds like prevention and describes something else: an ongoing course of treatment whose effects fade between sessions. Every repetition carries its own labelled risks, so the programme accumulates risk while the claim it rests on stays exactly as untested as it was at the beginning.
Starting younger
The claim that starting earlier gives a larger benefit is intuitive and, for anything except sun protection and not smoking, untested. It assumes that the mechanism of a treatment interacts with age in a way that has not been measured. For sun protection it is genuinely true and well supported, and that is where the intuition came from — the mistake is transferring it from a measure that has decades of population evidence to treatments that have none.
Claims the evidence does not carry
- That treating volume early prevents later loss.
- That stimulating collagen early prevents later laxity.
- That a maintenance programme is prevention rather than repeated treatment.
Each is stated with confidence, and none of the three is established.
Frequently asked questions
Does early filler prevent later volume loss?
Not supported. Filler adds volume to soft tissue where it is placed, and it does not stop the processes that reduce volume elsewhere or that change the skin. The comparison needed to show prevention — treated against untreated, over years, with a graded appearance — has not been made, and a face that is maintained is being treated rather than having stopped changing.
Does early collagen stimulation prevent laxity?
Not supported. The reasoning is that stimulating collagen while skin is healthy builds a reserve against later change. It is plausible and it has not been demonstrated, because demonstrating it would require following treated and untreated people long enough for laxity to develop and to be measured. No study of that kind exists for any device in this category.
Is a maintenance programme the same as prevention?
No. A maintenance programme is treatment that is repeated, and repeating it keeps its effects present without preventing anything. The distinction matters because repeated treatment adds risks every time, and a programme that continues indefinitely accumulates them — while the claim it rests on stays exactly as untested as it was at the start.
Risks & Limitations
- A face with no findings has no measurable baseline, so a preventive benefit cannot be demonstrated while the risks of treatment remain real.
- Nothing is approved with a preventive indication for facial ageing; approvals are for treating a change that is already present.
- Sun protection and not smoking are the only preventive measures with substantial support, and neither needs a clinical treatment.
- Treating early or maintaining a result is not prevention, and repeated treatment accumulates the labelled risks.
- A claim that nothing could contradict is a claim that cannot be supported either, and this category's claims are of that kind.
When to Seek Care
- A mole or patch that is changing in size, shape or colour — have it assessed by a clinician.
- A lesion that bleeds, itches or will not heal — have it assessed by a clinician.
- Blistering, crusting or pigment change that follows a device treatment — have it assessed by a clinician.
- Severe pain, dusky or mottled skin, or a change in vision after an injection — seek emergency care immediately.
References & Further Reading
- World Health Organization (WHO) — ultraviolet radiation and skin cancer prevention guidance
- U.S. Food and Drug Administration (FDA) — approved products and devices and their labelled indications
- National Medical Products Administration (NMPA, China) — approved products and their indications
- Cochrane Library — systematic reviews of photoprotection and topical treatments
- Chinese Medical Association Dermatology Branch — clinical guidance
This page is a review of published evidence and regulation, not medical advice, and it does not cite individual studies. It is not a booking page and it does not recommend a treatment, for or against. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.